Author name: Leonardo Arias

The sector recorded 12 bankruptcy filings in the first quarter, up 33% from the fourth quarter of 2025, according to the analysis by Gibbins Advisors.

The strike force allows the department’s healthcare fraud unit to coordinate with U.S. attorney’s offices in Arizona, Nevada and the Northern District of California, where the DOJ says fraud schemes are increasing.

Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

Passage Bio, which has been working toward a registrational trial for a drug candidate whose indications include frontotemporal dementia, is exploring strategic alternatives in addition to cutting staff.

The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.

Hologic, Teleflex, Grail and others are welcoming new CEOs, while STAAR Surgical is searching for its next leader. Read MedTech Dive’s roundup for all the details.

Comprehending the spate of recent rejections in the cell and gene therapy space may require looking no further than early-stage clinical trials of candidates from REGENXBIO, Excision BioTherapeutics and Intellia Therapeutics.

Most states are planning to adopt less restrictive policies to verify compliance with work requirements mandated by the “Big Beautiful Bill” passed last year, but some are implementing the policies early or checking eligibility more frequently. 

A pesar de afectar a la mitad de la población mundial, la menopausia ha sido históricamente poco estudiada y comprendida, tanto en la investigación biomédica como en la práctica clínica. No obstante, con el aumento de la esperanza de vida, la cantidad de muj …

Las pantallas táctiles, desde las de los teléfonos móviles y tabletas hasta las de los cajeros automáticos, se han convertido en elementos omnipresentes en nuestro día a día. Su uso frecuente provoca que se conviertan en reservorios de microorganismos y posi …